Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]
News [5292]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
Cell-culture based test systems for anticancer drug screening
Cell-culture based test systems for anticancer drug screening
A 'switch' that turns autoimmunity drugs into powerful anti-cancer treatments
A 'switch' that turns autoimmunity drugs into powerful anti-cancer treatments
ASCO 2020: Durvalumab added to standard chemotherapy improved overall survival in mesothelioma
ASCO 2020: Durvalumab added to standard chemotherapy improved overall survival in mesothelioma
New liver cancer research targets non-cancer cells to blunt tumour growth
New liver cancer research targets non-cancer cells to blunt tumour growth
FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high PD-L1 expression
FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high PD-L1 expression
FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer
FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer
New LAT1 inhibitor can boost cancer treatment
New LAT1 inhibitor can boost cancer treatment
FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumour expression ≥1%)
FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumour expression ≥1%)
FDA approves ripretinib for advanced gastrointestinal stromal tumour
FDA approves ripretinib for advanced gastrointestinal stromal tumour
FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation